Trishna Goswami
Directeur Technique/Scientifique/R&D chez IN8BIO, INC.
Fortune : 6 998 $ au 30/04/2024
Provenance du réseau au premier degré de Trishna Goswami
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Subsidiary | Biotechnology | 26 | |
14
| Public Company | Biotechnology | 14 |
| Subsidiary | Pharmaceuticals: Major | 4 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Trishna Goswami via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| CELGENE | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Director of Finance/CFO Compliance Officer Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
| TG THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| NATIONAL HOLDINGS CORPORATION | Investment Banks/Brokers | Director/Board Member | |
| ACADIA REALTY TRUST | Real Estate Investment Trusts | Director/Board Member | |
| SEAGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Director/Board Member Sales & Marketing | |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Pharmaceuticals: Other | Public Communications Contact Corporate Secretary | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO General Counsel Chief Operating Officer | |
| University of Virginia | College/University | Undergraduate Degree Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| GW PHARMACEUTICALS PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin | |
| Yale University | College/University | Undergraduate Degree Doctorate Degree Graduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Doctorate Degree Masters Business Admin Masters Business Admin | |
| State University of New York at Albany | College/University | Undergraduate Degree Undergraduate Degree | |
Gilead Connecticut, Inc.
 Gilead Connecticut, Inc. Pharmaceuticals: MajorHealth Technology Gilead Connecticut, Inc. manufactures pharmaceuticals and biotechnology chemicals. The firm develops a pipeline of small molecule therapeutics for multiple oncology and immunology-based indications. It focuses on the development of novel kinase inhibitors for the treatment of cancer, autoimmune, and inflammatory diseases. The company was founded in 2000 and is headquartered in Foster City, CA. | Pharmaceuticals: Major | Director/Board Member | |
| Ludwig-Maximilians-Universität München | College/University | Graduate Degree Undergraduate Degree | |
| Supreme Court of the United States | General Government | Corporate Officer/Principal | |
New York State Bar Association
 New York State Bar Association Miscellaneous Commercial ServicesCommercial Services New York State Bar Association is a non-profit organization, which provides legal services and offers a membership program for lawyers. It also publishes an array of books, bar journals, law digest, and State Bar news. The company was founded in 1876 and is headquartered in Alban, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| FORTY SEVEN, INC. | Pharmaceuticals: Major | President Director/Board Member | |
Kirby Mcinerney LLP
 Kirby Mcinerney LLP Miscellaneous Commercial ServicesCommercial Services Kirby McInerney LLP is a plaintiffs' law firm based in the United States that specializes in complex financial litigation and dispute resolution for institutional and individual clients. The private company is based in New York, NY. The company's areas of focus include securities, antitrust, whistleblower, and consumer litigation, among others. The firm has a successful track record in securities litigation, having recovered billions of dollars for shareholders. Kirby McInerney's website provides additional information about the firm. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Columbia Law School | College/University | Graduate Degree | |
| United States District Court for the Eastern District of NY | General Government | Corporate Officer/Principal | |
| United States District Court for the Southern District of NY | General Government | Corporate Officer/Principal | |
| The University of North Carolina at Charlotte | College/University | Doctorate Degree Graduate Degree | |
| United States Court of Appeals For The Fourth Circuit | Corporate Officer/Principal | ||
| JOUNCE THERAPEUTICS, INC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| AXCA HEALPAR | Biotechnology | Director/Board Member Private Equity Investor | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| Columbia Business School | College/University | Masters Business Admin Masters Business Admin | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Frontier Equities VC LLC
 Frontier Equities VC LLC Investment ManagersFinance Frontier Equities VC LLC (Frontier Equities) is a venture capital firm founded in 2011 by Mark Sard. The firm is headquartered in New York, United States. | Investment Managers | Founder | |
| POSEIDA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Aadi Subsidiary, Inc.
 Aadi Subsidiary, Inc. BiotechnologyHealth Technology Aadi Subsidiary, Inc. engages in biopharmaceutical company. Its therapeutic programs include pulmonary arterial hypertension, pediatric solid tumors, solid tumors with mTOR activation and mitochondrial disease. The company was founded by Neil Desai and is headquartered in Pacific Palisades, CA. | Biotechnology | Director/Board Member Chief Executive Officer | |
Gilead Sciences Ltd.
 Gilead Sciences Ltd. Medical DistributorsDistribution Services Founded in 1990, Gilead Sciences Ltd. is a pharmaceutical wholesaler that is part of Gilead Sciences, Inc. The company is based in London, UK and specializes in the distribution of pharmaceutical products. | Medical Distributors | Director/Board Member Director/Board Member | |
Greenwich Biosciences, Inc.
 Greenwich Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Greenwich Biosciences, Inc. develops and markets cannabinoid prescription medicines through online. The company is headquartered in Carlsbad, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| AUTOLUS THERAPEUTICS PLC | Biotechnology | Director/Board Member Director/Board Member | |
| PYXIS ONCOLOGY, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ACRIVON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| AADI BIOSCIENCE, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
Terremoto Biosciences, Inc.
 Terremoto Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Terremoto Biosciences, Inc. is a drug discovery and development company that creates highly targeted, small molecule medicines with unmatched selectivity, potency, and efficacy to deliver superior therapeutic benefit to patients. The company is based in San Francisco, CA. Terremoto is supported by leading investors, including OrbiMed, Third Rock Ventures, EcoR1 Capital, Novo Holdings, and Cormorant Capital. The company aims to expand the universe of drug targets and improve existing medicines by unleashing the power of covalent chemistry. Terremoto was founded by Peter A. Thompson and Matthew P. Jacobson, and Peter A. Thompson has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member | |
Lirum Therapeutics, Inc.
 Lirum Therapeutics, Inc. BiotechnologyHealth Technology Lirum Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the treatment of deliberating diseases. The firm is also involved in the acquisition, development, and commercialization of drug candidates. Its products include LX-101, a targeted therapy directed to the insulin-like growth factor 1 (IGF-1R). The company was founded in November 2021 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member | |
Mallinckrodt LLC
 Mallinckrodt LLC Pharmaceuticals: MajorHealth Technology Mallinckrodt LLC is proud to be one of the world's largest suppliers of both controlled substance pain medication and acetaminophen and to have over a century of leadership in helping to diagnose disease through imaging procedures. They are focused on innovative research and development programs, strong clinician relationships and a collaborative approach to new business opportunities. In short, they aim to lead a new generation of patient care by pursuing better, safer, more cost effective ways of diagnosing and treating disease to improve patient outcomes. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
| ADAPTIMMUNE THERAPEUTICS PLC | Biotechnology | Director of Finance/CFO Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 45 |
| Royaume-Uni | 5 |
| France | 2 |
| Allemagne | 2 |
Sectorielle
| Health Technology | 27 |
| Consumer Services | 14 |
| Finance | 4 |
| Government | 4 |
| Commercial Services | 4 |
Opérationnelle
| Director/Board Member | 196 |
| Corporate Officer/Principal | 102 |
| Independent Dir/Board Member | 59 |
| Undergraduate Degree | 38 |
| Chief Executive Officer | 25 |
Relations les plus connectées
| Insiders | |
|---|---|
| Peter Hutt | 69 |
| Luba Greenwood | 32 |
| Khalid Islam | 29 |
| Barbara Duncan | 22 |
| Alan Roemer | 21 |
| Scott Canute | 17 |
| Robert Azelby | 15 |
| Darren Cline | 15 |
| Brett Pletcher | 15 |
| Daniel Hume | 14 |
| Andrew Dickinson | 13 |
| Loretta Itri | 12 |
| Behzad Aghazadeh | 12 |
| Charles Baum | 12 |
| Brendan Delaney | 11 |
- Bourse
- Insiders
- Trishna Goswami
- Connexions Sociétés
